BioMed Research International

BioMed Research International / 2019 / Article

Research Article | Open Access

Volume 2019 |Article ID 6545210 | 12 pages | https://doi.org/10.1155/2019/6545210

New Gene Markers of Angiogenesis and Blood Vessels Development in Porcine Ovarian Granulosa Cells during Short-Term Primary Culture In Vitro

Academic Editor: Richard Tucker
Received27 Aug 2018
Revised19 Oct 2018
Accepted29 Nov 2018
Published30 Jan 2019

Abstract

The physiological processes that drive the development of ovarian follicle, as well as the process of oogenesis, are quite well known. Granulosa cells are major players in this occurrence, being the somatic element of the female gamete development. They participate directly in the processes of oogenesis, building the cumulus-oocyte complex surrounding the ovum. In addition to that, they have a further impact on the reproductive processes, being a place of steroid sex hormone synthesis and secretion. It is known that the follicle development creates a major need for angiogenesis and blood vessel development in the ovary. In this study, we use novel molecular approaches to analyze markers of these processes in porcine granulosa cultured primarily in vitro. The cells were recovered from mature sus scrofa specimen after slaughter. They were then subjected to enzymatic digestion and culture primarily for a short term. The RNA was extracted from cultures in specific time periods (0h, 24h, 48h, 96h, and 144h) and analyzed using expression microarrays. The genes that exhibited fold change bigger than , and adjusted p-value lower than 0.05, were considered differentially expressed. From these, we have chosen the members of “angiogenesis,” “blood vessel development,” “blood vessel morphogenesis,” “cardiovascular system development,” and “vasculature development” for further selection. CCL2, FGFR2, SFRP2, PDPN, DCN, CAV1, CHI3L1, ITGB3, FN1, and LOX which are upregulated, as well as CXCL10, NEBL, IHH, TGFBR3, SCUBE1, IGF1, EDNRA, RHOB, PPARD, and SLITRK5 genes whose expression is downregulated through the time of culture, were chosen as the potential markers, as their expression varied the most during the time of culture. The fold changes were further validated with RT-qPCR. The genes were described, with special attention to their possible function in GCs during culture. The results broaden the general knowledge about GC’s in vitro molecular processes and might serve as a point of reference for further in vivo and clinical studies.

1. Introduction

In the Graafian follicle, apart from the oocyte, distinct populations of somatic cells, called the granulosa cells (GCs), can be distinguished. Their functions include androgen to estrogen conversion, as well as synthesis of progesterone. Additionally, they engage in a bidirectional dialog with the oocyte, ensuring its competence for reproduction [1]. They are the innermost of the cells that surround the cumulus-oocyte complex. Processes in which they participate include the oogenesis, oocyte storage, and its maturation, all accompanied by close mutual interactions between the somatic cells and the gamete [24]. The granulosa cells provide the microenvironment necessary for development of the follicle and oocyte maturation [57]. They also influence the development of the female gamete in a paracrine and autocrine manner [8].

During the luteal phase of the menstrual cycle, the GCs undergo a transformation resulting in the formation of the corpus luteum [9]. Understanding the molecular mechanisms regulating that process is essential for completely understanding the regulation of oogenesis and ovarian function.

One of the effects of pituitary gonadotropin on the GCs is the upregulation of genes associated with the processes of angiogenesis and blood vessel development in the follicular microenvironment. These processes are essential for follicle and corpus luteum development. So far, there have only been a few reports describing genes responsible for blood vessels development, morphogenesis, and blood circulation in porcine oocytes [10]. Because of structural limitation, including the presence of theca layers, it is very interesting whether GCs have the possibility and genetic basis for the development of blood vessels network in the long period of follicular development.

The hormone-producing granulosa functions due to the formation of a complex capillary network in the ovary, which allows for oxygen, nutrient, and precursor transport. Without these, the synthesis and release of the range of ovarian hormones would not be possible. [11]. Several experimental models have demonstrated that ovarian function is critically dependent on angiogenesis during follicular development, ovulation, and corpus luteum function [12]. The inhibition of the angiogenetic and blood vessel development processes causes the impairment of follicle growth and ovulation disruption, as well as significant defects of corpus luteum function and development. [13].

DNA microarrays are a useful diagnostic method to examine changes in gene expression among granulosa cells and oocytes at various developmental stages [7]. The transcriptome analysis of GCs could be a powerful tool to improve our knowledge about the pathways involved in oocyte development [1]. However, to the best of our knowledge, gene expression profiles and identification of mechanisms, in which GCs form vessel microenvironment, have not yet been reported.

In this study, we performed in vitro cultures of porcine granulosa cells. We have investigated the transcriptomic profile changes of genes involved in “Angiogenesis,” “Blood vessel development,” “Blood vessel morphogenesis,” “Cardiovascular system development,” and “Vasculature development” during the short-term primary in vitro culture.

2. Materials and Methods

2.1. Animals

40 crossbred gilts belonging to a local Landrace were used in the study. They had a mean age of 170 days and weight of 98kg. The feeding, breeding and housing conditions of all the animals were identical. Poznan University of Medical Sciences Bioethical Committee approved the study by resolution 32/2012.

2.2. Collection of Porcine Ovaries and In Vitro Culture of Granulosa Cells

After slaughter, the reproductive tracts of the animal specimen were transported to the laboratory at 38°C in 0.9% NaCl within 30 min. Ovaries (n=80) were extracted from the tracts and placed in fetal bovine serum (FBS; Sigma-Aldrich Co., St. Louis, MO, USA) supplemented PBS. The follicles were visually measured, with those of the estimated diameter greater than 5mm (n=300) opened through puncture with a 5mm syringe and 20-G needle. This operation was performed in a sterile Petri dish, with the cumulus-oocyte complexes (COCs) and follicular fluid (FF) recovered. The GCs were extracted from the aspired follicular fluid, with the COCs discarded. Follicular fluid from each batch (collected from 20 gilts, 40 ovaries) of the specimen was pooled and treated as one biological sample. GCs were extracted from the fluid through centrifugation at 200 x g for 10 min and removal of remnant supernatant. The pellet was then suspended in the culture medium and, after counting, seeded onto culture dishes.

The number of cells per 1 mL of medium was counted using ADAM Automatic Cell counter (NanoEnTek, Pleasanton, CA, USA). The total volume of GC containing medium was then fractioned accordingly to the count readings and seeded onto 25cm2 culture bottles (Nunclon, Thermo-Fisher Scientific, Waltham, MA, USA). Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-Aldrich, USA), 2% fetal calf serum (FCS) (PAA, Linz, Austria), 10 mg/ml ascorbic acid (Sigma-Aldrich, USA), 0.05 μM dexamethasone (Sigma-Aldrich, USA), 200 mM L-glutamine (Invitrogen, USA), 10 mg/ml gentamycin (Invitrogen, USA), 10,000 units/ml penicillin, and 10,000 μg/ml streptomycin (Invitrogen, USA) were all of the components of the used culture medium. Cell cultivation was conducted at 38.5°C under 5% CO2 aerobic conditions. Cell detachment using 0.05% trypsin-EDTA (Invitrogen, USA) for 3 min and sample collection was performed on days 1, 2, 4, and 6 of the culture. The Z2 counter or cell viability analyzer (Vi-Cell XR 2.03; both Beckman Coulter, USA) was used to count the number of cells in samples.

2.3. Microarray Expression Analysis and Statistics

The Affymetrix was conducted as previously described by Trejter et al. [14]. RNA was isolated from each sample using the Chomczyński-Sacchi method [15]. Two rounds of sense cDNA amplification were applied to the resulting RNA samples (Ambion® WT Expression Kit). Biotin labelling and fragmentation were applied to the cDNA, Affymetrix GeneChip® WT Terminal Labeling and Hybridization (Affymetrix). The labelled cDNA fragments (5.5 μg) were hybridized to Affymetrix® Porcine Gene 1.1 ST Array Strip (48°C/20 h). The microarrays were then washed and stained, following the Affymetrix GeneAtlas Fluidics Station technical protocol. Imaging Station of GeneAtlas System was then employed to scan the stained chips. After reading, the scanned data was subjected to preliminary analysis using Affymetrix GeneAtlas™ Operating Software. The software provided criteria that were used to check the quality of gene expression data. Downstream data analysis was conducted using the obtained CEL files. Bioconductor and R programming language were used to obtain all of the analyses and graphs. The CEL files were merged with files that contained their description. The Robust Multiarray Averaging (RMA) algorithm was used for background correction, normalization, and a summary of the results. All of the microarrays were performed on 2 biological replicates, 3 technical repeats each. The repeats were averaged to present the best approximate value for each biological replicate. The mean of these values was used as the level of gene expression.

The lists of differentially up- and downregulated genes were uploaded to the DAVID software (Database for Annotation, Visualization and Integrated Discovery) and subjected to enriched Gene Ontology term extraction. Ontology groups that contained at least 5 genes and expressed p-value<0.05 were selected for further analysis. Particularly, the “angiogenesis”, “blood vessel development,” “blood vessel morphogenesis,” “cardiovascular system development,” and “vasculature development” were selected as Gene Ontology Biological Process Terms (GO BPs) of interest. Hierarchical clusterization procedure was applied to gene expression data which allowed presenting them as heatmaps.

The mutual relations between the gene sets of interest were investigated using the GOplot package [16]. Moreover, the package allowed for calculation of the z-score (the number of upregulated genes minus the number of downregulated genes divided by the square root of the count). Analysis of this score allowed for the comparison of selected GO BP terms.

96 genes, belonging to “angiogenesis,” “blood vessel development,” “blood vessel morphogenesis,” “cardiovascular system development,” and “vasculature development” GO BP terms, were the focus of this manuscript. 10 genes with the most upregulated downregulated expression levels were chosen to be analyzed in detail. STRING10 (Search Tool for the Retrieval of Interacting Genes) software allowed for the analysis of the interactions between proteins coded by the genes of interest and the gene itself. Information on protein/gene interactions, that include experimental data, computational prediction methods, and public text collections are all available in that database. Its engine allowed us to generate a molecular interaction network between the genes of interest. The search was based on cooccurrences of genes/proteins in scientific texts (textmining), coexpression, and experimentally observed interactions.

Finally, REACTOME FIViz to the Cytoscape 3.6.0 software was used to analyze the functional interactions between the genes belonging to the chosen gene ontologies. This app serves in finding pathways and network patterns related to cancer and other disease types. It accesses the Reactome database, reading through the stored pathways, which allows for the analysis of gene set pathway enrichment, visualization of hit pathways with the use of manually laid out pathway diagrams, and investigation of functional relationships between the analyzed genes.

2.4. Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) Analysis

RNA samples extracted from the different periods of primary culture of the analyzed cells were subjected to treatment with DNase I and reverse-transcription (RT) into cDNA. LightCycler real-time PCR detection system (Roche Diagnostics GmbH, Mannheim, Germany) was used to perform the RT-qPCR analysis, with SYBR® Green I used as a detection dye, and target cDNA quantification using the relative method. The internal glyceraldehyde-3-phosphate dehydrogenase (GAPDH) standard was used to standardize the relative levels of PTX3, COX2, HAS2, and TSG6 transcripts in all of the samples. 2 μl of cDNA solution, 18 μl of QuantiTect® SYBR® Green PCR (Master Mix Qiagen GmbH, Hilden, Germany), and primers (Table 1) constituted the full PCR reaction mix. The negative control was achieved through processing of one RNA sample from each preparation without PCR reaction.


Official gene symbolFold Change 0/48hFold Change 0/99hFold Change 0/144hadj.p.Value 0/48hadj.p.Value 0/98hadj.p.Value 0/144hENTREZ GENE ID

CXCL100,0366889890,0277437010,0309788243,47E-061,07E-061,53E-063627
NEBL0,0374277270,0373031490,0347293169,56E-073,68E-074,09E-0710529
IHH0,0497709280,0537999160,0477378032,16E-061,06E-061,09E-063549
TGFBR30,0658781610,0452878930,0462198864,56E-071,51E-071,50E-077049
SCUBE10,0844511850,0634513180,0871177684,12E-061,09E-062,53E-0680274
IGF10,1198405980,1807806710,3913693899,96E-050,0001722590,0062835053479
EDNRA0,1272831970,3820414410,2431074112,22E-064,49E-057,90E-061909
RHOB0,1365374360,3606121760,1630086974,89E-067,24E-054,71E-06388
PPARD0,1564577050,0378742360,061670458,24E-063,18E-077,27E-075467
SLITRK50,2191262240,0961986040,1246469961,47E-059,47E-071,93E-0626050
CCL212,3175453228,0402064824,47925841,00E-061,62E-072,27E-076347
FGFR214,0283168715,2134304917,309514271,48E-065,90E-075,70E-072263
SFRP215,3447071430,7920183438,319926319,81E-071,80E-071,50E-076423
PDPN18,988884418,6557525622,397753282,14E-051,11E-051,07E-0510630
DCN21,5863160816,8522343663,382484644,36E-072,52E-079,57E-081634
CAV122,315574510,4332030328,121258164,28E-074,59E-071,50E-07857
CHI3L129,639080633,55356095410,035579761,36E-050,0014336687,23E-051116
ITGB329,9125459339,8519895457,682118013,52E-071,21E-079,57E-083690
FN135,3789619666,1651001668,741847763,59E-079,92E-089,57E-082335
LOX67,3383823988,9507260975,584915032,15E-079,14E-089,57E-084015

PBGD and ACTB housekeeping gene levels were used to calculate the relative levels of the GC specific gene expression. 18S rRNA was used as an additional internal standard, allowing the demonstration of lack of differential regulation of the other housekeeping genes in the culture, as it has been defined as an appropriate gene for this task in quantitative PCR studies. All of the RT-qPCR analyses were performed on 2 biological replicates, 3 technical repeats each. The repeats were averaged to present the best approximate value for each biological replicate. The mean of these values was used as the level of gene expression.

2.5. Statistical Analysis

Bioconductor and R programming languages (R version 3.5.1) served to perform the statistical analysis of the results in this study. Statistical significance of the gene of interest expression was determined using the moderated t-statistics from the empirical Bayes method. Benjamini and Hochberg’s false discovery rate was employed to correct the p-value for multiple comparisons. P<0.05 was considered to indicate a statistically significant difference. The enriched GO term statistical significance test was performed using DAVID database software (v.6.8). The Benjamini method was used for that task. Each GO term was considered significantly enriched if it contained at least 5 differently expressed genes and showed P<0.05. RT-qPCR result statistical analysis was conducted using MS Excel 2016 Real Statistics Resource Pack add-on.

3. Results

The changes in the expression of GC genes were analyzed using the expression microarrays, after 2, 4, and 6 days of culture. Presence of 27558 transcripts has been identified. After selection based on fold change higher than and p-value<0.05, a set of 3380 differentially expressed genes has been identified.

The gene ontology terms were extracted with the use of DAVID (Database for Annotation, Visualization and Integrated Discovery) software. Overall, after subjecting up- and downregulated gene sets to the DAVID search and selecting only those of adjusted p-value<0.05, 344 GO BP terms containing the differentially expressed genes have been identified.

“Angiogenesis,” “blood vessel development,” “blood vessel morphogenesis,” “cardiovascular system development,” and “vasculature development” gene ontologies were the focus of this paper. Hierarchical clusterization procedure was applied to these gene sets, which allowed for presenting their changes in expression as heatmaps (Figure 1). Additionally, Table 1 was compiled to provide the complete gene symbols, fold changes in expression, Entrez gene IDs, and corrected p-values of these genes.

The enrichment levels of all of the GO BP terms of interest were further analyzed, being expressed as a z-score and presented in a form of circular visualization (Figure 2). The gene expression profiles were then hierarchically clustered to improve the understanding of the interactions between chosen gene ontologies. The results, in the form of dendrogram combined with fold changes of studied genes, are presented as Figure 3.

From the 96 differentially expressed genes of interest, 10 most upregulated and 10 most downregulated ones were chosen for the downstream analysis.

As genes can belong to multiple gene ontologies, the intersections of genes between the selected GO BPs were analyzed. The results of that analysis were presented as a circle plot (Figure 4) and heatmap (Figure 5).

Next, a molecular interaction network between the genes of interest was investigated using STRING software. The results, based on several association criteria, were presented as a STRING graph (Figure 6.). Finally, the functional interactions between the genes of interest were investigated using REACTOME FIViz app to Cytoscape 3.6.0 software. The results were presented as Figure 7.

Additionally, all of the microarray results were validated using RT-qPCR. The results were compared and presented as a bar graph (Figure 8). As can be seen, in most examples the direction of changes was confirmed. The only exceptions are PPARD and CHI3L1. First of these genes showed the different direction of expression change in hours 48 and 96, and the same direction as microarrays in hour 144. The second gene showed the same direction of changes in expression in hour 48, with the results differing between the two methods in hours 96 and 144. On the other hand, the scale of change in gene expression varied when analyzed with microarrays and RT-qPCR. In some examples, the variation was very small (DCN, CXCL10), while some genes showed a significant difference (IHH, NEBL, and SFRP2).

4. Discussion

In the growing ovarian follicle, in addition to the oocyte, separate somatic cell populations are also present. Theca cells, forming internal and external theca layers, reside outwardly and are separated from the internal layer of granulosa cells through the basal membrane. Under the influence of blood flow, from penetrating vessels to the basement membrane of the follicle, both of these layers are gradually differentiated [6]. Theca and granulosa cells participate in and promote the formation of corpus luteum. Theca cells are only correlated with the development of ovarian follicles. Two distinct granulosa cell populations exist in the mature vesicle: mural granulosa cells (GCs) and cumulus cells (CCs) directly related to the oocyte forming cumulus-oocyte complexes (COCs) [17]. GCs play an important role in folliculogenesis and ovarian follicle development process. Along with the development of the gap junction connections, they connect between themselves and with the oocyte. Bidirectional communication with the oocyte ensures the provision of nutrients essential for oocyte development. In addition, the natural roles of GCs include hormonal activity, with the production of estradiol during follicular growth and secretion of progesterone after ovulation [18]. The development of ovaries and ovarian follicles requires the expression of different genes appropriate for each developmental stage.

The development of new approaches, such as microarrays, opened new insights into GC functions and pathways that are activated during follicle development [19]. The microarray technique provides a global analysis of the transcriptome of a tissue and is a hypothesis-generating tool [20].

In our research, we paid particular attention to the study of the granulosa cells’ properties and their predisposition to participate in the angiogenesis and blood vessels development process in maturing ovarian follicle. A special focus was put on GCs that turn into ovarian corpus luteum. The growth and development of microvessels are extremely fast in female reproductive tissues. Hence, these tissues are highly vascularized in their mature state. Due to high vascularity, female reproductive tissues, especially corpus luteum, receive one of the highest blood flow rates per unit of tissue. The ovarian corpus luteum plays a key role in reproduction because it is the main source of circulating progesterone. After ovulation, corpus luteum, constructed among others from GCs, grows and vascularizes extremely quickly. In fact, the rate of tissue growth, development, and the process of corpus luteum angiogenesis are even faster than those of growing tumours [21]. The role of angiogenesis is important in solid tumour growth processes, as thanks to the increase of blood supply tumour growth is more intense [2225]. Thus, analysis of the genetic background and predicting of genes responsible for formation and development of blood vessels in GCs guarantee obtaining an excellent model for testing factors which regulate the process of angiogenesis and formation of new blood vessels. These are a critical moment for proper growth, development, and functioning of this ovarian tissue.

The purpose of this study was to analyze gene expression in porcine GCs, in order to define differentially expressed genes belongs to the “angiogenesis,” “blood vessel development,” “blood vessel morphogenesis,” “cardiovascular system development,” and “vasculature development” ontology groups during the long-term primary in vitro culture. This data points to a key role of genes belonging to these functional groups.

During our study, we have selected 10 most upregulated and 10 most downregulated genes that belong to these five ontology groups. In our research, by using microarray approach, we aimed to investigate the transcriptome profile of porcine granulosa cells, using total RNA isolated from before the primary culture and after 48h, 96h, and 144h of in vitro cultivation.

From 96 differently expressed genes belonging to the chosen ontology groups, we have selected CCL2, FGFR2, SFRP2, PDPN, DCN, CAV1, CHI3L1, ITGB3, FN1, and LOX which are upregulated, as well as CXCL10, NEBL, IHH, TGFBR3, SCUBE1, IGF1, EDNRA, RHOB, PPARD, and SLITRK5 genes whose expression is downregulated through the time of culture.

The most upregulated gene, belonging to the three of five analyzed ontology groups, is LOX (Lysyl oxidase) gene. We can find this gene in “blood vessel development,” “cardiovascular system development,” and “vasculature development” ontology groups. LOX encodes an extracellular amine oxidase, the primary function of which is the posttranslational modification of collagen and elastin in ECM (extracellular matrix). Thereby, it catalyzes covalent fibre cross-linking which may also occur during vessel formation [26]. Other upregulated genes, except for PDPN (Podoplanin), which represents only the “cardiovascular system development” and “vasculature development” ontology group, belong to all five analyzed groups. A study by Shindo et al. suggested that PDPN expression in stromal fibroblasts in pancreatic cancer was reported to be associated with vascular invasion [27]. This finding may indicate the importance of this gene in the blood vessels formation and rapid growth of cellular structures, which are undoubtedly specific for cancerous cells as well as granulosa cells examined by us. The next most upregulated gene just after LOX is FN1 (Fibronectin 1). Fibronectin (Fn) is one of the most abundant proteins of the cardiovascular system. It is a part of the fibrous extracellular matrix supporting endothelial cells. It also occurs, in a soluble form, at high concentrations in the blood [28]. Fn fibres form linear and branched meshes around cells and connect to neighbouring cells [29]. This protein exists in many isoforms generated by alternative splicing. For example, EIIIA/EIIIB double-null mice exhibit a requirement for these domains in the development of blood vessels during embryogenesis [28]. FN1 protein activates proteins encoded by ITGB3 (Integrin subunit beta 3), the next upregulated gene. Integrin signaling regulates various angiogenetic functions [30]. ITGB3 shows coexpression with FN1 gene and two of the analyzed, downregulated genes which are IGF1 (Insulin-like growth factor 1) and RHOB (Ras homolog family member B). RHOB was postulated to act as a tumour suppressor and regulate apoptosis. Overexpression of this gene inhibits proliferation, migration, and invasion of gastric carcinoma cells [31]. Gerald et al. have shown that loss of RHOB reduced the extent of pathological angiogenesis in the ischemic retina and led to reduced angiogenesis in response to skin wounds [32]. Several lines of evidence suggest that normal IGF-1 expression, contained only in the cardiovascular system, stimulates vascular health later in life [33]. This may explain down-expression of this gene in in vitro cultivated GCs. The IGF1 protein interacts with proteins encoded by two upregulated genes: DCN (Decorin) and FGFR2 (Fibroblast growth factor receptor 2). It is believed that DCN acts with IGF1, creating a protein complex, and it is involved in the regulation of angiogenesis with contradictory results. In terms of cancer, DCN has been shown to have a negative impact on tumour angiogenesis [34]. On the other hand, DCN has been shown to play a proangiogenic role, allowing adhesion of endothelial cells to type I collagen and α1β2 integrin, supporting the interaction between integrin and collagen [35]. Thus, considering our results and previous reports, it can be presumed that the effect of proangiogenic and antiangiogenic DCN activity depends mainly on the cellular and molecular microenvironment in which angiogenesis occurs. FGFR2 is a protein activated by the IGF1 protein. House et al. demonstrated that FGFR2 acts in endothelial cells, promoting cardiac functional recovery and vascular remodelling [36]. CAV1 (Caveolin 1) functions have been thoroughly examined using mouse knockouts. Work in this animal model has underlined the importance of CAV1 in modulating proliferation and vascular homeostasis [37]. Caveolin 1 may coexist with FN1 and ITGB3 proteins, forming two interactive complexes. CAV1 has also been shown to regulate the activity of key modulators of vasoactive pathways in endothelial cells. CAV1 deficiency affects the growth of structural disorders of blood vessels and induces pulmonary hypertension in mice and humans [38]. CHI3L1 (Chitinase 3 like 1), also named YKL-40, is a secreted glycoprotein. It acts as an angiogenic factor to promote tumour angiogenesis in GBM (malignant glioblastoma) and breast cancer. YKL-40 is an important factor that strongly induces angiogenesis of endothelial cells. Combined antiangiogenic therapies targeted against CHI3L1 and VEGF can significantly reduce tumour angiogenesis and consequently inhibit tumour growth [39]. The last two upregulated genes are SFRP2 (Secreted frizzled-related protein 2) and CCL2 (C-C motif chemokine ligand 2). Both of them show a similar level of expression during GCs’ long-term in vitro culture. Previous studies of SFRP2 only indicate that this gene is overexpressed in the vascular system of 85% of patients with breast cancer. Hence, its expression is closely related to cancer development [40]. Interestingly SFRP2 and CCL2 show coexpression with genes belonging to the downregulated group. CCL2 interacts with CXCL10 (C-X-C motif chemokine ligand 10) and PPARD (Peroxisome proliferator-activated receptor delta gene), while SFRP2 acts with IHH (Indian hedgehog). IHH and PPARD belong to “cardiovascular system development” ontology group. Interestingly, it has been shown that progesterone rapidly induces IHH expression in the mouse endometrium [41, 42]. This may explain the decrease in expression of this gene during long-term in vitro culture carried out without the addition of this hormone. SCUBE1 (Signal peptide CUB domain and EGF like domain containing 1), NEBL (Nebulette), and SLITRK5 (SLIT and NTRK like family member 5) belong to one and the same ontological group, similarly, to IGF1, PPARD, and IHH. SCUBE1 was first identified in vascular endothelial cells and is released, in the presence of activated platelets, in the circulatory system [43]. NEBL encodes a nebulin-like protein that is abundantly expressed in the myocardium. This protein may be involved in cardiac myofibril assembly [44]. SLITRK5 is expressed primarily in nervous tissues, exhibiting neurite-modulating activity [45]. TGFBR3 (Transforming growth factor beta receptor 3) plays an important role in epicardial development and coronary artery growth [46]. Decreased expression of this receptor has been observed in various cancers. The last downregulated gene, from those analyzed, is EDNRA (Endothelin receptor type A). This gene is expressed in all five groups, showing no correlation with the previously tested genes. EDNRA controls the production of the type A endothelin receptor and is expressed primarily in vascular muscle cells, regulating their vasoconstriction. Animal models have shown that the expression of the EDNRA protein is significantly reduced in the uteroplacental vascular bed [47]. Most of the downregulated genes are specific for cardiovascular system development and other tissues. This finding explains their expression reduction in GCs’ primary in vitro culture.

In conclusion, we identified several genes in porcine ovarian granulosa cells that were differentially expressed during the short-term primary in vitro culture. The presented data show, for the first time, variable levels of these genes’ expression and morphological changes in short-term in vitro culture of those cells. We have extracted two group of genes belonging to five ontological groups: “angiogenesis” (GO:0001525), “blood vessel development” (GO:0001568), “blood vessel morphogenesis” (GO:0048514), “cardiovascular system development” (GO:0072358), and “vasculature development” (GO:0001944) containing genes that are primarily responsible for the formation of new blood vessels. One of these groups consists of genes upregulated during cultivation, which may be the markers of these processes in the cultured GCs. As we mentioned above, these genes are mostly specific for forming cancerous tumours. Our research is in line with previous reports about similar dynamics and developmental potential of GCs and cancer cells. This is manifested by the activation of genes that directly take part in the formation of new blood vessels. It may reflect the ability of GCs to rapidly proliferate and differentiate into corpus luteum. These results will help in further elucidating the molecular basis and functional meaning of several gene markers involved in angiogenesis and blood vessel development in ovarian tissue.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

All the participants of the study were included as authors. Publication of this article was made possible by grants numbers UMO-2016/21/B/NZ9/03535 and UMO-2012/07/N/NZ5/00069 from Polish National Centre of Science.

References

  1. M. D’Aurora, S. Sperduti, G. Di Emidio, L. Stuppia, P. G. Artini, and V. Gatta, “Inside the granulosa transcriptome,” Gynecological Endocrinology, vol. 32, no. 12, pp. 951–956, 2016. View at: Publisher Site | Google Scholar
  2. W. Kranc, J. Budna, R. Kahan et al., “Molecular basis of growth, proliferation, and differentiation of mammalian follicular granulosa cells,” Journal of Biological Regulators and Homeostatic Agents, vol. 31, no. 1, pp. 1–8, 2017. View at: Google Scholar
  3. W. Kranc, J. Budna, M. Dudek et al., “The origin, in vitro differentiation, and stemness specificity of progenitor cells,” Journal of Biological Regulators and Homeostatic Agents, vol. 31, no. 2, pp. 365–369, 2017. View at: Google Scholar
  4. J. Budna, P. Celichowski, P. Karimi et al., “Does porcine oocytes maturation in vitro is regulated by genes involved in transforming growth factor beta receptor signaling pathway?” Advances in Cell Biology, vol. 5, no. 1, pp. 1–14, 2017. View at: Publisher Site | Google Scholar
  5. C. Lan, M. Chen, K. Tai et al., “Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling,” Scientific Reports, vol. 5, no. 1, 2015. View at: Publisher Site | Google Scholar
  6. M. Rybska, S. Knap, M. Jankowski et al., “Characteristic of factors influencing the proper course of folliculogenesis in mammals,” Medical Journal of Cell Biology, vol. 6, no. 1, pp. 33–38, 2018. View at: Publisher Site | Google Scholar
  7. M. Rybska, S. Knap, M. Jankowski et al., “Cytoplasmic and nuclear maturation of oocytes in mammals – living in the shadow of cells developmental capability,” Medical Journal of Cell Biology, vol. 6, no. 1, pp. 13–17, 2018. View at: Publisher Site | Google Scholar
  8. M. Orisaka, K. Tajima, B. K. Tsang, and F. Kotsuji, “Oocyte-granulosa-theca cell interactions during preantral follicular development,” Journal of Ovarian Research, vol. 2, no. 1, article 9, 2009. View at: Publisher Site | Google Scholar
  9. J. C. Havelock, W. E. Rainey, and B. R. Carr, “Ovarian granulosa cell lines,” Molecular and Cellular Endocrinology, vol. 228, no. 1-2, pp. 67–78, 2004. View at: Publisher Site | Google Scholar
  10. M. J. Nawrocki, P. Celichowski, J. Budna et al., “The blood vessels development, morphogenesis and blood circulation are three ontologic groups highly up-regulated in porcine oocytes before in vitro maturation,” Advances in Cell Biology, vol. 5, no. 2, pp. 135–142, 2017. View at: Publisher Site | Google Scholar
  11. M. M. Kaczmarek, D. Schams, and A. J. Ziecik, “Role of vascular endothelial growth factor in ovarian physiology - an overview,” Reproductive Biology and Endocrinology, vol. 5, no. 2, pp. 111–36, 2005. View at: Google Scholar
  12. N. C. Douglas, H. Tang, R. Gomez et al., “Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse,” Endocrinology, vol. 150, no. 8, pp. 3845–3854, 2009. View at: Publisher Site | Google Scholar
  13. R. S. Robinson, K. J. Woad, A. J. Hammond, M. Laird, M. G. Hunter, and G. E. Mann, “Angiogenesis and vascular function in the ovary,” Reproduction, vol. 138, no. 6, pp. 869–881, 2009. View at: Publisher Site | Google Scholar
  14. M. Trejter, A. Hochol, M. Tyczewska et al., “Sex-related gene expression profiles in the adrenal cortex in the mature rat: Microarray analysis with emphasis on genes involved in steroidogenesis,” International Journal of Molecular Medicine, vol. 35, no. 3, pp. 702–714, 2015. View at: Publisher Site | Google Scholar
  15. P. Chomczynski and N. Sacchi, “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,” Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987. View at: Google Scholar
  16. W. Walter, F. Sánchez-Cabo, and M. Ricote, “GOplot: An R package for visually combining expression data with functional analysis,” Bioinformatics, vol. 31, no. 17, pp. 2912–2914, 2015. View at: Publisher Site | Google Scholar
  17. R. J. Kordus and H. A. LaVoie, “Granulosa cell biomarkers to predict pregnancy in ART: Pieces to solve the puzzle,” Reproduction, vol. 153, no. 2, pp. R69–R83, 2017. View at: Publisher Site | Google Scholar
  18. E. Dzafic, M. Stimpfel, and I. Virant-Klun, “Plasticity of granulosa cells: On the crossroad of stemness and transdifferentiation potential,” Journal of Assisted Reproduction and Genetics, vol. 30, no. 10, pp. 1255–1261, 2013. View at: Publisher Site | Google Scholar
  19. E. Chronowska, “High-throughput analysis of ovarian granulosa cell transcriptome,” BioMed Research International, vol. 2014, Article ID 213570, 7 pages, 2014. View at: Publisher Site | Google Scholar
  20. F. C. Dias, M. I. Khan, M. A. Sirard, G. P. Adams, and J. Singh, “Transcriptome analysis of granulosa cells after conventional vs long FSH-induced superstimulation in cattle,” BMC Genomics, vol. 19, no. 1, 2018. View at: Publisher Site | Google Scholar
  21. H. M. Fraser and C. Wulff, “Angiogenesis in the corpus luteum,” Reproductive Biology and Endocrinology, vol. 1, article no. 88, 2003. View at: Publisher Site | Google Scholar
  22. P. Sujka-Kordowska, A. Malińska, and M. Zabel, “Selected aspects of angiogensis in haematological malignancies,” Advances in Cell Biology, vol. 2011, pp. 165–187, 2011. View at: Google Scholar
  23. A. Konwerska, B. Janik, A. Malinska, W. Witkiewicz, and M. Zabel, “The contribution of endothelial marker proteins in the determination of vascular angiogenic potential, in normal physiological conditions and in neoplasia,” Advances in Cell Biology, vol. 3, no. 4, pp. 69–83, 2011. View at: Publisher Site | Google Scholar
  24. K. Sterzynska, P. Sujka-Kordowska, and W. Witkiewicz, “The most important angiogenic growth factors influencing the development and function of blood vessels - in the context of coronary artery bypass grafting (CABG),” Advances in Cell Biology, vol. 3, no. 3, pp. 55–67, 2011. View at: Publisher Site | Google Scholar
  25. A. Knopik-Skrocka, P. Krȩplewska, and D. Jarmołowska-Jurczyszyn, “Tumor blood vessels and vasculogenic mimicry - Current knowledge and searching for new cellular/molecular targets of anti-angiogenic therapy,” Advances in Cell Biology, vol. 5, no. 1, pp. 50–71, 2017. View at: Publisher Site | Google Scholar
  26. C. Peng, J. Liu, G. Yang, and Y. Li, “Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: Quantum dot-based identification of biomarkers in cancer stromal cells,” International Journal of Nanomedicine, vol. 13, pp. 161–174, 2018. View at: Publisher Site | Google Scholar
  27. K. Shindo, S. Aishima, K. Ohuchida et al., “Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas,” Molecular Cancer, vol. 12, no. 1, 2013. View at: Google Scholar
  28. P. Singh, C. Carraher, and J. E. Schwarzbauer, “Assembly of fibronectin extracellular matrix,” Annual Review of Cell and Developmental Biology, vol. 26, pp. 397–419, 2010. View at: Publisher Site | Google Scholar
  29. L. B. Chen, A. Murray, R. A. Segal, A. Bushnell, and M. L. Walsh, “Studies on intercellular LETS glycoprotein matrices,” Cell, vol. 14, no. 2, pp. 377–391, 1978. View at: Publisher Site | Google Scholar
  30. J. S. Desgrosellier and D. A. Cheresh, “Integrins in cancer: biological implications and therapeutic opportunities,” Nature Reviews Cancer, vol. 10, no. 1, pp. 9–22, 2010. View at: Publisher Site | Google Scholar
  31. F. M. Vega, M. Thomas, N. Reymond, and A. J. Ridley, “The Rho GTPase RhoB regulates cadherin expression and epithelial cell-cell interaction,” Cell Communication and Signaling, vol. 13, no. 1, 2015. View at: Google Scholar
  32. D. Gerald, I. Adini, S. Shechter et al., “RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription,” Nature Communications, vol. 4, article 2824, 2013. View at: Publisher Site | Google Scholar
  33. Z. Ungvari and A. Csiszar, “The emerging role of IGF-1 deficiency in cardiovascular aging: Recent advances,” The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 67, no. 6, pp. 599–610, 2012. View at: Publisher Site | Google Scholar
  34. T. Neill, L. Schaefer, and R. V. Iozzo, “Instructive roles of extracellular matrix on autophagy,” The American Journal of Pathology, vol. 184, no. 8, pp. 2146–2153, 2014. View at: Publisher Site | Google Scholar
  35. L. R. Fiedler and J. A. Eble, “Decorin regulates endothelial cell-matrix interactions during angiogenesis,” Cell Adhesion & Migration, vol. 3, no. 1, pp. 3–6, 2009. View at: Publisher Site | Google Scholar
  36. S. L. House, A. M. Castro, T. S. Lupu et al., “Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 310, no. 5, pp. H559–H571, 2016. View at: Publisher Site | Google Scholar
  37. B. Razani, J. A. Engelman, X. B. Wang et al., “Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities,” The Journal of Biological Chemistry, vol. 276, no. 41, pp. 38121–38138, 2001. View at: Google Scholar
  38. Y.-Y. Zhao, Y. D. Zhao, M. K. Mirza et al., “Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration,” The Journal of Clinical Investigation, vol. 119, no. 7, pp. 2009–2018, 2009. View at: Publisher Site | Google Scholar
  39. R. Shao, S. L. Taylor, D. S. Oh, and L. M. Schwartz, “Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization,” Oncotarget , vol. 6, no. 38, pp. 40507–40518, 2015. View at: Publisher Site | Google Scholar
  40. A. Courtwright, S. Siamakpour-Reihani, J. L. Arbiser et al., “Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathway,” Cancer Research, vol. 69, no. 11, pp. 4621–4628, 2009. View at: Publisher Site | Google Scholar
  41. N. Takamoto, B. Zhao, S. Y. Tsai, and F. J. DeMayo, “Identification of Indian hedgehog as a progesterone-responsive gene in the murine uterus,” Molecular Endocrinology, vol. 16, no. 10, pp. 2338–2348, 2002. View at: Publisher Site | Google Scholar
  42. H. Matsumoto, X. Zhao, S. K. Das, B. L. M. Hogan, and S. K. Dey, “Indian hedgehog as a progesterone-responsive factor mediating epithelial-mesenchymal interactions in the mouse uterus,” Developmental Biology, vol. 245, no. 2, pp. 280–290, 2002. View at: Publisher Site | Google Scholar
  43. G. Ozkan, S. Ulusoy, A. Menteşe, S. C. Karahan, and M. Cansiz, “New marker of platelet activation, SCUBE1, is elevated in hypertensive patients,” American Journal of Hypertension, vol. 26, no. 6, pp. 748–753, 2013. View at: Publisher Site | Google Scholar
  44. E. Purevjav, J. Varela, M. Morgado et al., “Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis,” Journal of the American College of Cardiology, vol. 56, no. 18, pp. 1493–1502, 2010. View at: Publisher Site | Google Scholar
  45. J. Aruga, N. Yokota, and K. Mikoshiba, “Human SLITRK family genes: Genomic organization and expression profiling in normal brain and brain tumor tissue,” Gene, vol. 315, no. 1-2, pp. 87–94, 2003. View at: Publisher Site | Google Scholar
  46. D. M. DeLaughter, C. R. Clark, D. C. Christodoulou et al., “Transcriptional profiling of cultured, embryonic epicardial cells identifies novel genes and signaling pathways regulated by TGFβR3 in vitro,” PLoS ONE, vol. 11, no. 8, p. e0159710, 2016. View at: Publisher Site | Google Scholar
  47. A. W. Bigham, C. G. Julian, M. J. Wilson et al., “Maternal PRKAA1 and EDNRA genotypes are associated with birth weight, And PRKAA1 with uterine artery diameter and metabolic homeostasis at high altitude,” Physiological Genomics, vol. 46, no. 18, pp. 687–697, 2014. View at: Publisher Site | Google Scholar

Copyright © 2019 Błażej Chermuła et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1189 Views | 358 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.